Monitoring of plasma glucose using continuous glucose measurement system (CGMs) in patients with peritoneal dialysis
Not Applicable
- Conditions
- peritoneal dialysis patients
- Registration Number
- JPRN-UMIN000014916
- Lead Sponsor
- Department of Nephrology, Fujita Health University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Acute renal failure, severe liver dysfunction, peritonitis, perioperative patients , serious trauma, unstable heart disorder or cerebrovascular disease, infection, malignant tumor, pregnant women or women suspected of being pregnant, the subjects found offensive by attending physicians for this research, hypersensitivity with the DPP-4 inhibitor, history of diabetic ketoacidosis or diabetic coma, type I diabetes mellitus, taking the drug which is contraindicated to combination vildagliptin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma glucose profiling using CGM
- Secondary Outcome Measures
Name Time Method 1) blood parameters: CBC, biochemistry, HbA1c, GA, beta2 MG, MDA-LDL 2) fasting glood glusoce 3) ABI 4) peritoneal equilibration test